Tenon Medical financials
$2.73−4.55%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $1.4M | $1.5M | $1.2M | $564.0K | $726.0K | $770.0K | $887.0K | $901.0K | $719.0K | $808.0K | $944.0K |
| Gross profit | $814.0K | $945.0K | $1.0M | $773.0K | $245.0K | $323.0K | $353.0K | $418.0K | $470.0K | $470.0K | $559.0K | $535.0K |
| Gross margin | 63.6% | 68.5% | 68.7% | 65.9% | 43.4% | 44.5% | 45.8% | 47.1% | 52.2% | 65.4% | 69.2% | 56.7% |
| Operating income | -$3.4M | -$3.3M | -$2.9M | -$3.4M | -$2.9M | -$3.7M | -$3.2M | -$3.2M | -$3.9M | -$3.5M | -$3.1M | -$3.4M |
| Net income | -$4.0M | -$3.5M | -$2.8M | -$3.3M | -$2.8M | -$3.6M | -$3.1M | -$3.2M | -$3.8M | -$3.6M | -$3.1M | -$3.3M |
| Net margin | −316.7% | −252.1% | −191.2% | −284.7% | −491.0% | −498.1% | −400.9% | −359.0% | −424.6% | −497.4% | −387.9% | −353.0% |
| Diluted EPS | $-12.35 | $-10.85 | $-5.67 | $-14.00 | $-12.76 | $-35.35 | $-34.27 | $-127.05 | $-285.60 | $-350.70 | $-193.20 | $-409.15 |
| EBITDA | -$3.3M | -$3.2M | -$2.8M | -$3.3M | -$2.8M | -$3.6M | -$3.1M | -$3.1M | -$3.8M | -$3.4M | -$3.1M | -$3.3M |
| Operating cash flow | -$2.8M | -$3.0M | -$2.2M | -$3.8M | -$2.2M | -$2.5M | -$2.8M | -$2.3M | -$2.4M | -$2.3M | -$2.3M | -$3.2M |
| Free cash flow | -$2.9M | -$3.0M | -$2.4M | -$4.5M | -$2.4M | -$2.5M | -$2.8M | -$2.4M | -$2.4M | -$2.5M | -$2.4M | -$3.2M |
| Diluted shares | 0.3M | 0.3M | 0.5M | 0.2M | 0.2M | 0.1M | 0.1M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.7M | $4.6M | $3.8M | $3.4M | $7.8M | $10.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $4.3M | $3.5M | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $9.9M | $12.8M | $10.8M | $10.4M | $11.1M | $13.4M |
| Total liabilities | $11.7M | $10.9M | $5.7M | $5.6M | $4.4M | $4.0M |
| Shareholders' equity | -$1.7M | $1.9M | $5.0M | $4.8M | $6.7M | $9.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology